Page last updated: 2024-10-25

ciprofloxacin and von Willebrand Diseases

ciprofloxacin has been researched along with von Willebrand Diseases in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

von Willebrand Diseases: Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castaman, G2
Lattuada, A1
Mannucci, PM1
Rodeghiero, F2

Other Studies

2 other studies available for ciprofloxacin and von Willebrand Diseases

ArticleYear
Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor.
    American journal of hematology, 1995, Volume: 49, Issue:1

    Topics: Bleeding Time; Ciprofloxacin; Collagen; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Humans

1995
Acquired transitory von Willebrand syndrome with ciprofloxacin.
    Lancet (London, England), 1994, Feb-19, Volume: 343, Issue:8895

    Topics: Adult; Ciprofloxacin; Female; Humans; Male; von Willebrand Diseases

1994